Triazolam

CHEMBL646 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

343.2 g/mol

LogP

2.4

Phase

4

This short-acting benzodiazepine is prescribed for the short-term treatment of severe insomnia, particularly trouble falling asleep. It works by enhancing the calming effects of GABA in the brain to induce sleep. Due to its rapid action and potential for next-day memory problems, dependence, and rebound insomnia, it is recommended only for very short-term use.

Peso Molecular

343,2000 g/mol

LogP

2,40

TPSA

43,10 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pain Management Schizophrenia Generalized Anxiety Disorder Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2

InChI

InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3

Molecular Formula

C17H12Cl2N4

HBD / HBA

- / 3

Ligações Rotacionáveis

1

Átomos Pesados

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This short-acting benzodiazepine is prescribed for the short-term treatment of severe insomnia, particularly trouble falling asleep. It works by enhancing the calming effects of GABA in the brain to induce sleep. Due to its rapid action and potential for next-day memory problems, dependence, and rebound insomnia, it is recommended only for very short-term use.

Yes, Triazolam is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL646. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5556. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Triazolam no PillFYI

Estrutura

Dados Rápidos

Fórmula: C17H12Cl2N4
Sinônimos: 1

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.